| ¿µ¹® | resistance | ÇÑ±Û | ³»¼º, ÀúÇ×¼º |
|---|---|---|---|
| ¼³¸í | ¨ç ¾à¹°ÀÇ ¹Ýº¹ º¹¿ë¿¡ ÀÇÇØ ¾àÈ¿°¡ ÀúÇÏÇÏ´Â Çö»ó. ¨è ¼¼±Õ µûÀ§ÀÇ º´¿øÃ¼°¡ ÈÇÐ ¿ä¹ýÁ¦³ª Ç×»ý ¹°ÁúÀÇ °è¼Ó »ç¿ë¿¡ ´ëÇÏ¿© ³ªÅ¸³»´Â ÀúÇ×¼º. ¼¼±ÕÀÇ ³»¼ºÈ¹µæÀÇ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼´Â ¼¼Æ÷ÀÇ ±¸Á¶(¸®Æ÷Á», ¼¼Æ÷¸·) º¯È, ´ë»ç°èÀÇ º¯È, µ¹¿¬º¯ÀÌ µî¿¡ ÀÇÇÑ ¾à¹°°¨¼ö¼º ÀúÇÏ µîÀÌ ÃßÃøµÇ°í ÀÖ´Ù. ÇÑÆí ´Ù¸¥ ¾à¹°¿¡µµ ³»¼ºÀ» ³ªÅ¸³»´Â ±³Â÷³»¼º°ú, ¿©·¯ Á¾·ùÀÇ ¾à¹°¿¡ µ¿½Ã¿¡ ³»¼ºÀ» ȹµæÇÑ »óŸ¦ ´ÙÁ¦ ³»¼ºÀ̶ó°í ÇÑ´Ù. 3. ȯ°æ Á¶°ÇÀÇ º¯È¿¡ °ßµô ¼ö ÀÖ´Â »ý¹°ÀÇ ¼ºÁú. ³»¿¼º, ³»ÇѼº µûÀ§°¡ ÀÖ´Ù. |
||
| ¿µ¹® | drug resistance | ÇÑ±Û | ¾à¹°³»¼º |
|---|---|---|---|
| ¼³¸í | 1. ÈÇпä¹ýÁ¦³ª Ç×»ý¹°ÁúÀÇ ¾î¶² ÀÏÁ¤ ³óµµ·Î ¼¼±ÕÀ» Á×À̰ųª Áõ½ÄÀúÇØ¸¦ ¹Þ´Â °ÍÀ» ÀÌ ÈÇпä¹ýÁ¦³ª Ç×»ý¹°Áú¿¡ °¨¼ö¼ºÀÌ ÀÖ´Ù°í Çϴµ¥, ÀÌ °¨¼ö¼ºÀÌ ¾ø°Ô µÈ »ýŸ¦ ÀúÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. µû¶ó¼ º¯À̹̻ý¹°ÀÇ ¾àÁ¦¿¡ ´ëÇÑ ÀÚÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. 2. ÀǾàǰÀ» °è¼Ó º¹¿ëÇϸé Á¡Â÷ Áõ·®ÇÏÁö ¾ÊÀ¸¸é È¿·ÂÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¼ºÁú. ÀÌ·¯ÇÑ ¶§¸¦ ¾àÁ¦³»¼ºÀÌ »ý°å´Ù°í ÇÑ´Ù. ¸ðµç ¹Ì»ý¹°Àº °¨¼ö¼ºÀ» °¡Áö´Â ¾à¹°¿¡ ÀÇÇÏ¿© »ç¸êµÇÁö¸¸, ¼Ò¼öÀÇ °ÍÀº »ì¾Æ³²¾Æ ±×°ÍÀÌ ÁøÈµÊÀ¸·Î½á »ç¸êÇÏÁö ¾Ê´Â ¼ö°¡ ÀÖ´Ù. ¶Ç, ÃÖÃÊ¿¡´Â °¨¼ö¼ºÀ» °¡Áö°í ÀÖ´ø ±ÕÀÌ Â÷Â÷ ³»¼º±ÕÀ¸·Î µÇ±âµµ ÇÑ´Ù. ¸¹Àº º´¿ø±ÕÀº °¨¼ö¼ºÀÌ ÀÖ´Â ÀǾàǰ¿¡ ´ëÇÏ¿© ³»¼ºÀÌ »ý±ä´Ù. °¡Àå °íµµÀÇ ³»¼º±ÕÀÌ »ý±â±â ½¬¿î °ÍÀº ½ºÆ®·¾Å丶À̽ÅÀε¥ °áÇÙ±Õ°ú ±×¶÷À½¼º±Õ¿¡ ´ëÇÏ¿© ½±°Ô ³»¼ºÀÌ »ý±ä´Ù. Æä´Ï½Ç¸°À̳ª Åׯ®¶ó½ÃŬ¸°(¾ÆÅ©·Î¸¶À̽Å) µîÀÇ Ç×»ý¹°Áúµµ ³»¼ºÀÌ »ý±â±â ½¬¿ì¹Ç·Î, »ç¿ëÇÒ ¶§´Â ÀûÀÀÀ» Àß È®ÀÎÇÏ¿© Çʿ䷮À» Á¤ÇÏ°í ¿¬¿ëÀ» ÇÇÇÑ´Ù. °°Àº È¿°ú°¡ ÀÖ´Â ´Ù¸¥ Á¾·ùÀÇ ¾àÁ¦¸¦ ¼Ò·®¾¿ 2, 3Á¾ º´¿ëÇÏ¸é ³»¼ºÀÇ ¹ß»ýÀÌ Å©°Ô ¾ïÁ¦µÈ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. °áÇÙ¾àÀ¸·Î¼ ½ºÆ®·¾Å丶À̽Űú ÆÄ½º, ¶Ç´Â À̼ҴϾÆÁöµå¸¦ º´¿ëÇÏ´Â °Í µîÀÌ ±× ¿¹ÀÌ´Ù. |
||
| ¿µ¹® | resistance | ÇÑ±Û | ÀúÇ× |
|---|---|---|---|
| ¼³¸í | ¨ç¾à¹°ÀÇ ¹Ýº¹ º¹¿ë¿¡ ÀÇÇØ ¾àÈ¿°¡ ÀúÇÏÇÏ´Â Çö»ó. ¨è ¼¼±Õ µûÀ§ÀÇ º´¿øÃ¼°¡ ÈÇÐ ¿ä¹ýÁ¦³ª Ç×»ý ¹°ÁúÀÇ °è¼Ó »ç¿ë¿¡ ´ëÇÏ¿© ³ªÅ¸³»´Â ÀúÇ×¼º. ¼¼±ÕÀÇ ³»¼ºÈ¹µæÀÇ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼´Â ¼¼Æ÷ÀÇ ±¸Á¶(¸®Æ÷Á», ¼¼Æ÷¸·) º¯È, ´ë»ç°èÀÇ º¯È, µ¹¿¬º¯ÀÌ µî¿¡ ÀÇÇÑ ¾à¹°°¨¼ö¼º ÀúÇÏ µîÀÌ ÃßÃøµÇ°í ÀÖ´Ù. ÇÑÆí ´Ù¸¥ ¾à¹°¿¡µµ ³»¼ºÀ» ³ªÅ¸³»´Â ±³Â÷³»¼º°ú, ¿©·¯ Á¾·ùÀÇ ¾à¹°¿¡ µ¿½Ã¿¡ ³»¼ºÀ» ȹµæÇÑ »óŸ¦ ´ÙÁ¦ ³»¼ºÀ̶ó°í ÇÑ´Ù. ¨é ȯ°æ Á¶°ÇÀÇ º¯È¿¡ °ßµô ¼ö ÀÖ´Â »ý¹°ÀÇ ¼ºÁú. ³»¿¼º, ³»ÇѼº µûÀ§°¡ ÀÖ´Ù. |
||
| ¿µ¹® | percutaneous transluminal coronary angioplasty | ÇÑ±Û | °æÇǰæÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼ú=PTCA |
|---|---|---|---|
| ¼³¸í | ¼ö¼úÀ» ÇÏÁö ¾Ê°í ÀûÀº ÇÕº´ÁõÀ¸·Î ½ÉÀ嵿¸ÆÀÇ ¹Ý°æÀ» ´ÃÀÏ ¼ö ÀÖ´Â ¹æ¹ý. ½ÉÀ嵿¸Æ(Coronary artery)À̶õ, ½ÉÀåÀÇ Ç÷¾×À» °ø±ÞÇÏ´Â ½ÉÀå¿¡ Á¸ÀçÇÏ´Â µ¿¸ÆÀ» ¸»ÇÑ´Ù. ÀÌ·± ½ÉÀ嵿¸ÆÀÌ º´ÀûÀÎ »óÅ·Π±× ³»°ÀÌ Á¼¾ÆÁö°Ô µÇ¸é, ½ÉÀåÀÇ ÇãÇ÷ÀÌ ¹ß»ýÇÏ¿© À̸¥¹Ù Çù½ÉÁõÀ» À¯¹ßÇÏ°Ô µÇ°í, ½ÉÇÏ¸é ½ÉÀåÀÇ °æ»öÁõÀÌ ¹ß»ýÇÏ¸ç °á±¹Àº ȯÀÚÀÇ »ý¸íÀ» ¾Ñ¾Æ°£´Ù. µû¶ó¼ ÀÌ·± Á¼¾ÆÁø ½ÉÀ嵿¸ÆÀÌ ÀÖÀ¸¸é ³ÐÇôÁÖ¾î¾ß ÇÑ´Ù. ½ÉÀ嵿¸ÆÀ» ³ÐÇôÁÖ´Â ¹æ¹ýÀ¸·Î, Ç÷Àü¿¡ ÀÇÇÑ °æ¿ì ¾à¹°À» ÀÌ¿ëÇÏ¿© ¿ëÇØ½Ãų ¼öµµ ÀÖÀ¸³ª, ÀÌ¹Ì ¿À·¡µÈ °æ¿ì´Â ¾à¹°·Î½á Ä¡·á´Â ºÒ°¡´ÉÇÏ´Ù. À̶§ ¼ö¼úÀû ¹æ¹ý°ú ÀÌ °æÇÇÀû°æÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼úÀ» ½ÃÇàÇÑ´Ù. ¼ö¼úÀû ¹æ¹ýÀº Á÷Á¢ °¡½¿À» ¿°í ½ÉÀåÀÇ Á¼¾ÆÁø Ç÷°üÀ» Á¦°ÅÇÏ°í ´Ù¸¥ Ç÷°üÀ¸·Î ´ëÄ¡ÇÏ´Â µ¿¸ÆÀ̽ļúÀ̸ç, °æÇÇÀû°æÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼úÀº ÇǺθ¦ ÅëÇÏ¿© (°æÇÇÀû)ÇǺιØÀÇ µ¿¸ÆÀ» ã¾Æ, µ¿¸Æ¼ÓÀ» Áö³ª¼ (°æÇ÷°ü)½ÉÀ嵿¸Æ¿¡ À̸£·¯, µ¿¸ÆÀ» È®ÀåÇÏ´Â ¹æ¹ýÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | coronary artery bypass surgery | ÇÑ±Û | ½ÉÀ嵿¸Æ µÎ¸§±æ¼ö¼ú, ½ÉÀ嵿¸Æ¿ìȸ·Î ¼ö¼ú |
|---|---|---|---|
| ¼³¸í | ½ÉÀ嵿¸ÆÀ̶õ ½ÉÀå¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀ» À̸£´Â ¸»·Î ½ÉÀ忪½Ã ±ÙÀ°ÀÌ¾î¼ Ç÷¾×À» °ø±Þ¹Þ¾Æ¾ß ¼öÃàÀ» ÇÒ ¼ö°¡ ÀÖ´Ù. ½ÉÀ嵿¸ÆÀÌ Á¼¾ÆÁú °æ¿ì¿¡´Â ½ÉÀå¿¡ Ç÷¾×ÀÇ °ø±ÞÀÌ ¾ø¾îÁ®¼ ½ÉÀ嵿¸Æº´À̶ó´Â º´À» ÀÏÀ¸Å²´Ù. ½ÉÀ嵿¸Æ µÎ¸§±æ¼ö¼ú(coronary artery bypass surgery)À̶õ ½ÉÀ嵿¸Æº´¿¡¼ Á¼¾ÆÁø Ç÷°üºÎÀ§ ¶§¹®¿¡ »ý±â´Â Ç÷¾×°ø±ÞÀÌ Àû¾îÁø ºÎÀ§¿¡ Ç÷¾×°ø±ÞÀ» ¿øÈ°ÇÏ°Ô ÇØÁÖ´Â ¼ö¼ú¹æ¹ýÀ¸·Î ´Ù¸¥ ºÎÀ§ÀÇ Ç÷°üÀ̳ª ÀΰøÀûÀÎ ¹°ÁúÀ» ÀÌ¿ëÇØ¼ Á¼¾ÆÁø Ç÷°üºÎÀ§ÀÇ ¾Õ, µÚ¸¦ ¿¬°áÇÏ¿© Ç÷·ù°¡ Á¼¾ÆÁø ºÎºÐÀ» Áö³ªÁö ¾Ê°í »õ·Î ¿¬°áµÈ ºÎºÐÀ» Áö³ª°Ô ÇÏ¿© Ç÷·ù¸¦ Áõ°¡½ÃŰ´Â ¹æ¹ýÀÌ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| PVR | peripheral vascular resistance; perspective volume rendering; poliovirus receptor; postvoiding resid... |
| RVR | reduced vascular response; renal vascular resistance; repetitive ventricular response; resistance to... |
| TPVR | total peripheral vascular resistance; total pulmonary vascular resistance |
| IR | drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat... |
| CVR | Coronary vascular resistance |
|---|---|
| VEGF/VPF | Vascular endothelial growth factor/ vascular permeability factor |
| VPF/VEGF | Vascular permeability factor/vascular endothelial growth factor |
| CVR | Cerebral vascular resistance |
| FVR | Forearm vascular resistance |
| vascular resistance | An expression of the resistance offered by the systemic arterioles, and to a lesser extent by the capillaries, to the flow of blood. (12 Dec 1998) |
|---|---|
| resistance, vascular | The opposition to the flow of blood across a vascular bed. (12 Dec 1998) |
| systemic vascular resistance | An index of arteriolar compliance or constriction throughout the body; equal to the blood pressure divided by the cardiac output. (05 Mar 2000) |
| airway resistance | The opposition of the tracheobronchial tree to air flow: the mouth-to-alveoli pressure difference divided by the air flow. (12 Dec 1998) |
| ampicillin resistance | Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis. (12 Dec 1998) |
| androgen resistance syndromes | A class of disorders associated with 5a-steroid reductase deficiency, testicular feminization, and related disorders. Compare: steroid 5a-reductase, Reifenstein's syndrome, infertile male syndrome, testicular feminization syndrome. (05 Mar 2000) |
| antibiotic resistance | The ability of a bacterium tosynthesise a protein that neutralises an antibiotic. (09 Oct 1997) |
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| bacteriophage resistance | Resistance of a bacterial mutant to infection by a bacteriophage to which the parent (wild type) strain is susceptible. (05 Mar 2000) |
| beta-lactam resistance | Nonsusceptibility of an organism to the action of the beta-lactam antibiotics. (12 Dec 1998) |
| capillary resistance | The resistance offered to the flow of blood through the capillary portion of the peripheral vascular bed. (12 Dec 1998) |
| capillary resistance test | A tourniquet test used to determine presence of vitamin C deficiency or thrombocytopenia; a circle 2.5 cm in diameter, the upper edge of which is 4 cm below the crease of the elbow, is drawn on the inner aspect of the forearm, pressure midway between the systolic and diastolic blood pressure is applied above the elbow for 15 minutes, and a count of petechiae within the circle is made: 10, normal; 10 to 20, marginal zone; over 20, abnormal. See: Rumpel-Leede test. Synonym: capillary resistance test, vitamin C test. (05 Mar 2000) |
| resistance | The failure of a condition to respond or remit following treatment. (16 Dec 1997) |
| resistance, antibiotic | The ability of bacteria and other microorganisms to withstand an antibiotic to which they were once sensitive (and were once stalled or killed outright). Also called drug resistance. (12 Dec 1998) |
| resistance factor | <molecular biology> A self-replicating fragment of nucleic acid that confers drug resistance and is transmitted from one bacterium to another via conjugation. (09 Oct 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|